Vectron Biosolutions
PrivateLast Round
Series A
Jun 17, 2021
Total Funding Raised
$2.7M
Company Overview
Vectron Biosolutions operates in Healthcare & Life Sciences and is based in Trondheim. Its latest recorded funding round was a Series A round in June 2021.
Vectron Biosolutions is a biotechnology company that provides services and proprietary expression technology for the production of recombinant proteins in bacteria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vectron Biosolutions Comparables
Compare Vectron Biosolutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phenotypeca | 81% | |
| Acies Bio | 77% | |
| Isomerase Therapeutics Ltd. | 69% |
For institutional investors. Book with your work email.
Vectron Biosolutions Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Vectron Biosolutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dynamk Capital | Series A |
| Leiv Eiriksson Nyskaping | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Monthly visitors increased 40% MoM.
- Jun 17, 2021
$3M round led by Dynamk Capital
For institutional investors. Book with your work email.
Vectron Biosolutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vectron Biosolutions's valuation, stock price, and market status.
Is Vectron Biosolutions a public or private company?
Vectron Biosolutions is a private company.
What is the current stock price of Vectron Biosolutions?
Vectron Biosolutions is a private company, so its shares have no public market price. Caplight tracks Vectron Biosolutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vectron Biosolutions worth (valuation)?
Valuation information for Vectron Biosolutions is not publicly available.
Can I buy Vectron Biosolutions stock?
Vectron Biosolutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vectron Biosolutions's last funding round?
Vectron Biosolutions's most recent funding round was Series A on June 17, 2021.
Who are the main investors in Vectron Biosolutions?
Key investors in Vectron Biosolutions include Dynamk Capital.
Will Vectron Biosolutions IPO soon?
No public IPO plans have been announced for Vectron Biosolutions.
How can I track Vectron Biosolutions secondary market activity?
Caplight tracks bids, offers, and trades in Vectron Biosolutions's shares on secondary markets.